MedPath

Can Genetics Predict Treatment Response to a Computerized Self-help Program for Depression?

Not Applicable
Completed
Conditions
Major Depressive Disorder
Mood Disorders
Interventions
Behavioral: Computerized self-help program for depression
Registration Number
NCT01818453
Lead Sponsor
University of Texas at Austin
Brief Summary

The goal of this project is to determine whether genetic information can be used to predict response to an internet-based treatment of depression. Several studies now indicate that completing an internet-based treatment for depression, called Deprexis, can significantly improve symptoms of depression. However, not everyone improves. The purpose of this study is to determine whether genetic profile can predict who is likely to improve.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • English-speaking
  • Have reliable access to the internet (i.e., dialup or broadband access)
  • Be willing to donate saliva for DNA research
  • Have a current symptoms of depression
  • Be stable on medication and/or therapy (i.e. no changes within 2 weeks of study entry)
Exclusion Criteria
  • Any diagnosis of a psychotic or bipolar disorder
  • Meeting for alcohol/drug dependence in the past year
  • Having current suicidal risk warranting crisis intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Computerized self-help program for depressionComputerized self-help program for depressionParticipants will have access to a computerized self-help program for depression, called deprexis, for 8 weeks.
Primary Outcome Measures
NameTimeMethod
Quick Inventory of Depressive Symptomatology (Self-Report) (QIDS-SR-16)Administred every 2 weeks while the participant is engaged in the online deprexis treatment program to measure depression symptom severity.
Secondary Outcome Measures
NameTimeMethod
Inventory of Depression and Anxiety Symptoms (IDAS)The IDAS will be completed as part of the pre- and post-treatment questionnaires to assess for symptoms of depression and anxiety.
Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)The ATRQ will be administered as part of the pre-treatment questionnaires to evaluate psychotropic efficacy.
Hamilton Depression Rating Scale (HAM-D)The HAM-D will be completed during the pre- and post-treatment phone interviews to assess depression symptom severity.
Psychiatric Diagnostic Screening Questionnaire (PDSQ)The PDSQ will be completed as part of the pre- and post-treatment questionnaires to screen for the most common DSM-IV Axis I disorders..
Risky Families Questionnaire (RFQ)The RFQ will be completed as part of the pre-treatment questionnaires to assess early familial experiences and the harshness of family climate.
Sheehan Disability Scale (SDS)The SDS will be completed as part of the pre- and post-treatment questionnaires to evaluate symptom-related disability.

Trial Locations

Locations (1)

The University of Texas at Austin

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath